Brainstorm Cell Therapeutics (BCLI) Debt to Equity (2001 - 2026)
Brainstorm Cell Therapeutics (BCLI) debt to equity from Mar 31, 2001 to Mar 31, 2026. The current Brainstorm Cell Therapeutics (BCLI) debt to equity is -12.08%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Brainstorm Cell Therapeutics (BCLI)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | -9.72% | +151.41% |
| 2024 | -3.87% | N/A |
| 2023 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
| 2008 | 0.00% | N/A |
| 2007 | 0.00% | N/A |
| 2006 | 0.00% | N/A |
| 2006 | 0.00% | N/A |
| 2005 | 0.00% | N/A |
| 2004 | 0.00% | N/A |
| 2003 | 0.00% | N/A |
| 2002 | 0.00% | N/A |
| 2001 | 0.00% | N/A |
Comparison Brainstorm Cell Therapeutics (BCLI) debt to equity with competitors
Brainstorm Cell Therapeutics (BCLI) debt to equity is -12.08%.